Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
4
×
life sciences
national blog main
national top stories
new york blog main
4
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
bristol-myers squibb
clinical trials
crispr
medicare
merck
novartis
pfizer
venture capital
abeona therapeutics
accent therapeutics
achilles therapeutics
What
patients
4
×
market
bio
drug
medicine
roundup
advantages
bar
becker
benefiting
billions
boston
brings
cancer
coming
diagnostics
dollars
eaton
eisai
expect
fda
flags
gamble
gene
glimcher
groundbreaking
headline
healthcare
higher
impact
incidence
keynote
laurie
life
lorcaserin
loss
marketing
medco’s
michael
millions
Language
unset
Current search:
patients
×
cancer
×
" new york blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September